(S1 (S (NP (NN Airway) (NN epithelial) (NNS cells)) (VP (VBP do) (RB not) (ADVP (RB significantly)) (VP (VB upregulate) (NP (NN caspase-1) (NN activity)) (PP (IN in) (NN response) (TO to) (NP (NN inflammasome) (NN stimulation)))))))
(S1 (S (S (S (VP (TO To) (VP (VB examine) (SBAR (IN if) (S (NP (NN inflammasome) (NN activation)) (VP (VBZ occurs) (PP (IN in) (NP (DT these) (NN airway) (NNS cells))))))))) (, ,) (NP (NN caspase-1) (NN activity)) (VP (VBD was) (VP (VBN quantified) (PP (IN by) (NP (NN flow) (NN cytometry)))))) (. .)))
(S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN increase)) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (JJ live) (NN PAO1)) (CC or) (NP (NN LPS+ATP))))))) (PP (IN at) (NP (NP (DT the) (NNS times)) (VP (VBN examined) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 3a-b))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (SBAR (IN Because) (S (NP (JJ previous) (NNS studies)) (VP (VBP have) (VP (VBN indicated) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN caspase-1))) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN through) (NP (NP (NP (JJ Toll-like) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TLR)) (-RRB- -RRB-))) (NN signaling)))))) (PRN (-LRB- -LSB-) (NP (CD 35)) (-RRB- -RSB-)))))) (, ,) (NP (PRP we)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NP (JJ chemical) (NN inhibition)) (PP (IN of) (NP (NN caspase-1)))) (VP (VBD altered) (NP (JJ NF-kappaB-dependent) (NN IL-6) (NN production)) (PP (IN in) (NN response) (TO to) (NP (FW P.) (FW aeruginosa))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (DT the) (NN caspase-1) (NP (NN inhibitor) (NN z-YVAD-fmk))) (PRN (-LRB- -LRB-) (NP (NN YVAD)) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB decrease) (NP (NN IL-6) (NN secretion)) (PP (IN by) (NP (NP (NN airway) (JJ epithelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3c)) (-RRB- -RRB-))))))) (. .)))
